Yahoo Web Search

Search results

1. • 

     The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?

     Investor's Business Daily· 2 days ago

     Shares initially soared on June 6 — though ultimately closed down almost 7% — after Novavax said in...

2. • 

     Novavax seeks FDA nod for updated COVID-19 vaccine By Investing.com

     Investing.com· 1 day ago

     Novavax , Inc. (NASDAQ: NASDAQ:NVAX) has announced its submission for an amended Emergency Use...

3. • 

     Healthy Returns: What we know about the next round of Covid vaccines

     CNBC· 3 days ago

     Here's what we know about the newest vaccines so far. The Food and Drug Administration on Friday...

4. • 

     New COVID-19 strain KP.3 circulating in US. What is the situation in Riverside County?

     The Desert Sun· 1 day ago

     A new COVID-19 variant called KP.3 is on the rise in the United States and has been detected in...

5. • KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms

     USA TODAY via Yahoo News· 2 days ago

     During the Vaccines and Related...health experts from vaccine manufacturers Pfizer, Moderna and Novavax each told the panel they were ...

6. • 

     Moderna (MRNA) Submits Updated COVID-19 Jab to FDA for Review

     Zacks via Yahoo Finance· 6 days ago

     Moderna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19...

7. • 

     Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal

     Zacks via Yahoo Finance· 23 hours ago

     Data from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...

8. • 

     Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?

     Investor's Business Daily· 3 days ago

     Moderna also recently gained FDA approval for its second product, the RSV shot. In older adults, the...

9. • 

     Moderna Falls, Though Says Covid/Flu Shot Topped Rivals

     Investor's Business Daily· 5 days ago

     In a study of about 8,000 people, Moderna's combination vaccine proved it's not inferior to the...

10. • 

      Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing

      BioPharma Dive via Yahoo Finance· 2 days ago

      The Japanese pharma paid $100 million to secure option rights to an Ascentage drug. Elsewhere, J.P....